Medtronic scraps plans to buy EOFlow

Medtronic called off its planned acquisition of EOFlow, a maker of insulin patch-pumps, citing multiple breaches of agreements. The deal was valued at about $738 million.

“Medtronic called off its plans to buy EOFlow, a company making an insulin patch-pump that is embroiled in a patent dispute with Insulet, Medtronic said in a Wednesday filing with the U.S. Securities and Exchange Commission.”medtechdive.com

• 1 source
• medtechdive.comMedtronic scraps plans to buy insulin patch-pump maker EOFlow | MedTech DiveElise ReuterDec 7, 2023

Summarized from public sources; check the original articles before acting on it.